IndraLab

Statements

Gefitinib inhibits NFKBIA. 1 / 1

| 1

reach

"Gefitinib combined with PDTC can inhibit P-IkappaBalpha production and NF-kappaB P-p50 and P-p65 activation to suppress the survival of residual H1650 cells and the generation of gefitinib resistant cells."

29891456

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Gefitinib inhibits NFKBIA. 1 / 1

INDRA sources:

Databases

Reading